Aigen Investment Management LP acquired a new position in shares of Danaher Co. (NYSE:DHR – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 10,755 shares of the conglomerate’s stock, valued at approximately $2,990,000. Danaher accounts for about 0.6% of Aigen Investment Management LP’s holdings, making the stock its 20th largest holding.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. nVerses Capital LLC purchased a new position in Danaher during the second quarter valued at approximately $25,000. CarsonAllaria Wealth Management Ltd. acquired a new position in shares of Danaher in the 2nd quarter valued at $25,000. MFA Wealth Advisors LLC purchased a new stake in shares of Danaher during the 2nd quarter worth about $51,000. Financial Connections Group Inc. purchased a new stake in shares of Danaher in the second quarter valued at approximately $51,000. Finally, Western Pacific Wealth Management LP acquired a new position in shares of Danaher during the 1st quarter worth approximately $55,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have weighed in on the stock. Barclays reduced their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Stifel Nicolaus raised their price target on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Bank of America boosted their price objective on Danaher from $270.00 to $275.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 24th. KeyCorp raised their target price on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Finally, Wells Fargo & Company began coverage on Danaher in a research report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price target for the company. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $287.16.
Danaher Trading Up 0.1 %
DHR stock traded up $0.23 during midday trading on Tuesday, hitting $243.48. 229,920 shares of the company’s stock were exchanged, compared to its average volume of 2,735,948. Danaher Co. has a 1-year low of $193.75 and a 1-year high of $281.70. The business has a 50-day simple moving average of $264.37 and a two-hundred day simple moving average of $260.82. The stock has a market capitalization of $175.86 billion, a PE ratio of 46.42, a P/E/G ratio of 4.51 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the company earned $2.02 EPS. On average, sell-side analysts predict that Danaher Co. will post 7.51 EPS for the current fiscal year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date was Friday, September 27th. Danaher’s payout ratio is 20.61%.
Insider Transactions at Danaher
In other Danaher news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 11.10% of the company’s stock.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- Dividend Payout Ratio Calculator
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Investing In Preferred Stock vs. Common Stock
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- What Investors Need to Know to Beat the Market
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.